Astellas Pharma Inc.

OTC: ALPMF · Real-Time Price · USD
11.10
0.00 (0.00%)
At close: Aug 08, 2025, 2:03 PM

Astellas Pharma Cash Flow Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
31.24B 17.05B 132.36B 156.89B 145.32B
Depreciation & Amortization
199.13B 157.84B 105.74B 79.68B 72.65B
Stock-Based Compensation
n/a n/a n/a n/a n/a
Other Working Capital
-11.41B n/a 98.19B -16.64B 47.39B
Other Non-Cash Items
130.51B 84.11B 113.88B 14.92B 120.59B
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
-166.37B -86.52B -24.21B 5.96B -31.73B
Operating Cash Flow
194.51B 172.47B 327.77B 257.44B 306.84B
Capital Expenditures
-57.33B -82.5B -88.54B -76.45B -77.44B
Cash Acquisitions
n/a -784.97B n/a -670M -14.92B
Purchase of Investments
n/a n/a n/a -5.58B n/a
Sales Maturities Of Investments
12.92B n/a 12.62B 5.58B n/a
Other Investing Acitivies
-65.34B -22.77B -8.58B 14.71B 10.46B
Investing Cash Flow
-89.42B -845.8B -84.5B -62.41B -81.89B
Debt Repayment
-88.52B 771.23B -15B -60B -126B
Common Stock Repurchased
-6.96B -10.73B -60.56B -50.72B -9.16B
Dividend Paid
-128.99B -116.65B -100.36B -85.24B -76.16B
Other Financial Acitivies
-36.89B -29.79B -19.71B -20.34B -18.16B
Financial Cash Flow
-261.37B 614.06B -195.62B -216.3B -229.48B
Net Cash Flow
-147.31B -41.15B 60.85B -10.14B 7.74B
Free Cash Flow
137.18B 89.98B 239.23B 181B 229.4B